Treating MDA-MB-231 breast cancer cells with a PHD inhibitor, molidustad, which stabilized hypoxia-inducible factors, resulted in decreased viability, growth, and clone formation, induced cell cycle arrest, and chemosensitivity. The gene discussed is PDC; the disease is breast cancer.